PubMed

Reconsideration of severe hypoglycemic events in the treat-to-target trial.

Dailey G, Strange P, Riddle M.

Diabetes Technol Ther. 2009 Aug;11(8):477-9.PMID: 19698059 [PubMed - in process]Related articles

Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system.

Rovira X, Vivó M, Serra J, Roche D, Strange PG, Giraldo J.

Br J Pharmacol. 2009 Jan;156(1):28-35. Review.PMID: 19133989 [PubMed - indexed for MEDLINE]Related articles

Large-scale functional expression of WT and truncated human adenosine A2A receptor in Pichia pastoris bioreactor cultures.

Singh S, Gras A, Fiez-Vandal C, Ruprecht J, Rana R, Martinez M, Strange PG, Wagner R, Byrne B.

Microb Cell Fact. 2008 Oct 10;7:28.PMID: 18847468 [PubMed - in process]Related articlesFree article

Fewer academics are not the answer to funding woes.

Strange P.

Nature. 2008 Jul 24;454(7203):397. No abstract available. PMID: 18650888 [PubMed - indexed for MEDLINE]Related articles

Antipsychotic drug action: antagonism, inverse agonism or partial agonism.

Strange PG.

Trends Pharmacol Sci. 2008 Jun;29(6):314-21. Epub 2008 May 28. Review.PMID: 18471899 [PubMed - indexed for MEDLINE]Related articles

Signaling mechanisms of GPCR ligands.

Strange PG.

Curr Opin Drug Discov Devel. 2008 Mar;11(2):196-202. Review.PMID: 18283607 [PubMed - indexed for MEDLINE]Related articles

Dipolar excitations at the LIII x-ray absorption edges of the heavy rare-earth metals.

Brown SD, Strange P, Bouchenoire L, Zarychta B, Thompson PB, Mannix D, Stockton SJ, Horne M, Arola E, Ebert H, Szotek Z, Temmerman WM, Fort D.

Phys Rev Lett. 2007 Dec 14;99(24):247401. Epub 2007 Dec 13.PMID: 18233487 [PubMed]Related articles

Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.

Strange PG.

Br J Pharmacol. 2008 Apr;153(7):1353-63. Epub 2008 Jan 28. Review.PMID: 18223670 [PubMed - indexed for MEDLINE]Related articlesFree article

Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.

Dailey G, Strange P.

Am J Manag Care. 2008 Jan;14(1):25-30.PMID: 18197742 [PubMed - indexed for MEDLINE]Related articlesFree article

Basal-Prandial Insulin Delivery in Type 2 Diabetes Mellitus via the V-Go: A Novel Continuous Subcutaneous Infusion Device.

Kapitza C, Fein S, Heinemann L, Schleusener D, Levesque S, Strange P.

J Diabetes Sci Technol. 2008 Jan;2(1):40-6.PMID: 19885176 [PubMed - in process]Free article

Use of fourier models for analysis and interpretation of continuous glucose monitoring glucose profiles.

Miller M, Strange P.

J Diabetes Sci Technol. 2007 Sep;1(5):630-8.PMID: 19885131 [PubMed - in process]Free article

Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.

Haworth B, Lin H, Fidock M, Dorr P, Strange PG.

Biochem Pharmacol. 2007 Sep 15;74(6):891-7. Epub 2007 Jun 26.PMID: 17669370 [PubMed - indexed for MEDLINE]Related articles

Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.

Leach K, Charlton SJ, Strange PG.

Biochem Pharmacol. 2007 Sep 15;74(6):881-90. Epub 2007 Jun 20.PMID: 17645873 [PubMed - indexed for MEDLINE]Related articles

Mechanisms underlying agonist efficacy.

Strange PG.

Biochem Soc Trans. 2007 Aug;35(Pt 4):733-6. Review.PMID: 17635136 [PubMed - indexed for MEDLINE]Related articles

A first for men's health.

Strange P.

Aust Nurs J. 2007 Jul;15(1):33. No abstract available. PMID: 17628955 [PubMed - indexed for MEDLINE]Related articles

Creating a positive environment for men.

Strange P.

Aust Nurs J. 2007 Jul;15(1):31. No abstract available. PMID: 17628954 [PubMed - indexed for MEDLINE]Related articles

Not so good when 75% of grant applications fail.

Strange P.

Nature. 2007 Jul 5;448(7149):22. No abstract available. PMID: 17611521 [PubMed - indexed for MEDLINE]Related articles

Treat-to-Target Insulin Titration Algorithms When Initiating Long or Intermediate Acting Insulin in Type 2 Diabetes.

Strange P.

J Diabetes Sci Technol. 2007 Jul;1(4):540-8.PMID: 19885117 [PubMed - in process]Free article

Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation.

Quirk K, Roberts DJ, Strange PG.

Br J Pharmacol. 2007 May;151(1):144-52. Epub 2007 Mar 12.PMID: 17351658 [PubMed - indexed for MEDLINE]Related articlesFree article

Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.

Goggi JL, Sardini A, Egerton A, Strange PG, Grasby PM.

Synapse. 2007 Apr;61(4):231-41.PMID: 17230553 [PubMed - indexed for MEDLINE]Related articles

Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.

Lin H, Saisch SG, Strange PG.

Br J Pharmacol. 2006 Oct;149(3):291-9. Epub 2006 Aug 21.PMID: 16921389 [PubMed - indexed for MEDLINE]Related articlesFree article

Diverse signalling by different chemokines through the chemokine receptor CCR5.

Mueller A, Mahmoud NG, Strange PG.

Biochem Pharmacol. 2006 Sep 14;72(6):739-48. Epub 2006 Jul 17.PMID: 16844091 [PubMed - indexed for MEDLINE]Related articles

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team.

Diabetes Care. 2006 Jan;29(1):1-8.PMID: 16373887 [PubMed - indexed for MEDLINE]Related articlesFree article

Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

Bode BW, Steed RD, Schleusener DS, Strange P.

Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.

Vivo M, Lin H, Strange PG.

Mol Pharmacol. 2006 Jan;69(1):226-35. Epub 2005 Oct 4.PMID: 16204468 [PubMed - indexed for MEDLINE]Related articlesFree article

Oligomers of D2 dopamine receptors: evidence from ligand binding.

Strange PG.

J Mol Neurosci. 2005;26(2-3):155-60. Review.PMID: 16012188 [PubMed - indexed for MEDLINE]Related articles

Mechanisms of inverse agonist action at D2 dopamine receptors.

Roberts DJ, Strange PG.

Br J Pharmacol. 2005 May;145(1):34-42.PMID: 15735658 [PubMed - indexed for MEDLINE]Related articlesFree article

The influence of G protein subtype on agonist action at D2 dopamine receptors.

Nickolls SA, Strange PG.

Neuropharmacology. 2004 Nov;47(6):860-72.PMID: 15527820 [PubMed - indexed for MEDLINE]Related articles

Mechanisms of agonist action at D2 dopamine receptors.

Roberts DJ, Lin H, Strange PG.

Mol Pharmacol. 2004 Dec;66(6):1573-9. Epub 2004 Aug 31.PMID: 15340043 [PubMed - indexed for MEDLINE]Related articlesFree article

CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins.

Mueller A, Strange PG.

FEBS Lett. 2004 Jul 16;570(1-3):126-32.PMID: 15251452 [PubMed - indexed for MEDLINE]Related articles

Domain swapping in the human histamine H1 receptor.

Bakker RA, Dees G, Carrillo JJ, Booth RG, López-Gimenez JF, Milligan G, Strange PG, Leurs R.

J Pharmacol Exp Ther. 2004 Oct;311(1):131-8. Epub 2004 May 24.PMID: 15159444 [PubMed - indexed for MEDLINE]Related articlesFree article

Inverse agonist properties of atypical antipsychotic drugs.

Akam E, Strange PG.

Biochem Pharmacol. 2004 Jun 1;67(11):2039-45.PMID: 15135301 [PubMed - indexed for MEDLINE]Related articles

Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.

Roberts DJ, Lin H, Strange PG.

Biochem Pharmacol. 2004 May 1;67(9):1657-65.PMID: 15081865 [PubMed - indexed for MEDLINE]Related articles

Mechanisms of internalization and recycling of the chemokine receptor, CCR5.

Mueller A, Strange PG.

Eur J Biochem. 2004 Jan;271(2):243-52.PMID: 14717692 [PubMed - indexed for MEDLINE]Related articles

The chemokine receptor, CCR5.

Mueller A, Strange PG.

Int J Biochem Cell Biol. 2004 Jan;36(1):35-8. Review.PMID: 14592532 [PubMed - indexed for MEDLINE]Related articles

Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.

Gazi L, López-Giménez JF, Rüdiger MP, Strange PG.

Eur J Biochem. 2003 Oct;270(19):3928-38.PMID: 14511374 [PubMed - indexed for MEDLINE]Related articlesFree article

Small intestinal submucosa for laparoscopic repair of large paraesophageal hiatal hernias: a preliminary report.

Strange PS.

Surg Technol Int. 2003;11:141-3.PMID: 12931295 [PubMed - indexed for MEDLINE]Related articles

Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis.

Schwartz S, Sievers R, Strange P, Lyness WH, Hollander P; INS-2061 Study Team.

Diabetes Care. 2003 Aug;26(8):2238-43.PMID: 12882842 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacological analysis of a dopamine D(2Short):G(alphao) fusion protein expressed in Sf9 cells.

Gazi L, Wurch T, Lopéz-Giménez JF, Pauwels PJ, Strange PG.

FEBS Lett. 2003 Jun 19;545(2-3):155-60.PMID: 12804767 [PubMed - indexed for MEDLINE]Related articles

Characterization of the endokinins: human tachykinins with cardiovascular activity.

Page NM, Bell NJ, Gardiner SM, Manyonda IT, Brayley KJ, Strange PG, Lowry PJ.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):6245-50. Epub 2003 Apr 25.PMID: 12716968 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of molecular determinants of affinity and relative efficacy of a series of R- and S-2-(dipropylamino)tetralins at the 5-HT1A serotonin receptor.

Alder JT, Hacksell U, Strange PG.

Br J Pharmacol. 2003 Mar;138(6):1129-39.PMID: 12684269 [PubMed - indexed for MEDLINE]Related articlesFree article

Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity.

Nickolls SA, Strange PG.

Biochem Pharmacol. 2003 Apr 1;65(7):1139-50.PMID: 12663049 [PubMed - indexed for MEDLINE]Related articles

Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

Gazi L, Nickolls SA, Strange PG.

Br J Pharmacol. 2003 Mar;138(5):775-86.PMID: 12642378 [PubMed - indexed for MEDLINE]Related articlesFree article

Formation of oligomers by G protein-coupled receptors.

Gazi L, López-Giménez JF, Strange PG.

Curr Opin Drug Discov Devel. 2002 Sep;5(5):756-63. Review.PMID: 12630296 [PubMed - indexed for MEDLINE]Related articles

Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor.

Payne SL, Johansson AM, Strange PG.

J Neurochem. 2002 Sep;82(5):1106-17.PMID: 12358758 [PubMed - indexed for MEDLINE]Related articles

[How to investigate and analyze clinical incidents: a clinical risk protocol in association with litigation and risk management]

Vincent C, Taylor-Adams S, Chapman EJ, Hewett D, Prior S, Strange P, Tizard A.

Ann Fr Anesth Reanim. 2002 Jun;21(6):509-16. French. No abstract available. PMID: 12134595 [PubMed - indexed for MEDLINE]Related articles

Pharmacological characterization of the chemokine receptor, CCR5.

Mueller A, Mahmoud NG, Goedecke MC, McKeating JA, Strange PG.

Br J Pharmacol. 2002 Feb;135(4):1033-43.PMID: 11861332 [PubMed - indexed for MEDLINE]Related articlesFree article

Mechanisms of inverse agonism at G-protein-coupled receptors.

Strange PG.

Trends Pharmacol Sci. 2002 Feb;23(2):89-95. Review.PMID: 11830266 [PubMed - indexed for MEDLINE]Related articles

Pathways for internalization and recycling of the chemokine receptor CCR5.

Mueller A, Kelly E, Strange PG.

Blood. 2002 Feb 1;99(3):785-91.PMID: 11806977 [PubMed - indexed for MEDLINE]Related articlesFree article